WGC-26764-73610
3 vaccinations
1 coded response
33 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 482 / MI
- Registered
- 2021-01-20
- Relationship
- Self
- Race
- N/A
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-19
Dose 1 — Pfizer-BioNTech
-
2021-01-20
Registered in v-safe
- 2021-01-20
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-02-02
-
2021-02-09
Dose 2 — Pfizer-BioNTech
- 2021-02-09
-
2021-02-10
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-11
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-03-18
- 2021-03-23
- 2021-05-13
-
2021-10-22
Dose 3 — Pfizer-BioNTech
-
2021-10-23
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · HeadacheAdult check-in
- 2021-10-24
- 2021-10-25
- 2021-10-27
- 2021-10-28
- 2021-10-29
- 2021-11-07
- 2021-11-12
- 2021-11-21
- 2021-11-29
-
2021-12-04
Survey response — day 42, dose 3MedDRA: Headache, Pregnancy, Vision blurred — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Blurred vision and intense headache. This is believed to be linked to pregnancy and not the Pfizer VaccinationMedDRA releases: 2024-11 · check-in free text available
-
2021-12-04
Report sent to call center — day 42, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2021-12-07
- 2022-04-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-19 | Pfizer-BioNTech | |
| 2 | 2021-02-09 | Pfizer-BioNTech | |
| 3 | 2021-10-22 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-12-04 | Unsuccessful |
Free text
Release 10 — day 42, dose 3
Symptoms: Blurred vision and intense headache. This is believed to be linked to pregnancy and not the Pfizer Vaccination
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Vision blurred | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release